Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 29 | 2025 | 652 | 4.920 |
Why?
|
| Genetic Vectors | 25 | 2025 | 808 | 4.090 |
Why?
|
| Genetic Therapy | 16 | 2025 | 733 | 1.850 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2017 | 142 | 1.290 |
Why?
|
| Transduction, Genetic | 7 | 2024 | 228 | 1.280 |
Why?
|
| Osteoblasts | 6 | 2019 | 195 | 1.140 |
Why?
|
| Capsid | 3 | 2024 | 88 | 1.060 |
Why?
|
| Transgenes | 7 | 2025 | 177 | 1.040 |
Why?
|
| Codon | 1 | 2025 | 48 | 0.940 |
Why?
|
| Retina | 1 | 2024 | 115 | 0.870 |
Why?
|
| Nanopores | 1 | 2022 | 10 | 0.810 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1304 | 0.810 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 297 | 0.810 |
Why?
|
| Gene Expression | 4 | 2019 | 810 | 0.790 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 359 | 0.750 |
Why?
|
| Gene Transfer Techniques | 8 | 2021 | 303 | 0.670 |
Why?
|
| Osteogenesis | 3 | 2017 | 140 | 0.640 |
Why?
|
| Animals | 32 | 2025 | 19678 | 0.630 |
Why?
|
| Genome, Viral | 5 | 2024 | 122 | 0.620 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 74 | 0.610 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 101 | 0.600 |
Why?
|
| Promoter Regions, Genetic | 7 | 2024 | 652 | 0.600 |
Why?
|
| Mice | 23 | 2025 | 10309 | 0.600 |
Why?
|
| Genome | 2 | 2017 | 257 | 0.580 |
Why?
|
| CCCTC-Binding Factor | 1 | 2017 | 40 | 0.570 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 30 | 0.570 |
Why?
|
| Genes, Reporter | 4 | 2019 | 241 | 0.470 |
Why?
|
| Eukaryota | 1 | 2014 | 29 | 0.450 |
Why?
|
| Cell Line | 8 | 2019 | 1984 | 0.400 |
Why?
|
| Organ Specificity | 2 | 2025 | 183 | 0.380 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 77 | 0.380 |
Why?
|
| Genomics | 1 | 2014 | 322 | 0.370 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1554 | 0.360 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 87 | 0.360 |
Why?
|
| Humans | 28 | 2025 | 59458 | 0.330 |
Why?
|
| MicroRNAs | 3 | 2021 | 618 | 0.330 |
Why?
|
| Genetic Engineering | 3 | 2019 | 111 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3241 | 0.320 |
Why?
|
| Liver | 2 | 2025 | 796 | 0.290 |
Why?
|
| HEK293 Cells | 4 | 2025 | 587 | 0.280 |
Why?
|
| Gene Editing | 3 | 2021 | 299 | 0.280 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 188 | 0.270 |
Why?
|
| Gene Silencing | 2 | 2019 | 378 | 0.270 |
Why?
|
| DNA, Circular | 1 | 2025 | 7 | 0.240 |
Why?
|
| Plasmids | 2 | 2023 | 279 | 0.230 |
Why?
|
| Carcinogenesis | 2 | 2023 | 118 | 0.230 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1206 | 0.220 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 19 | 0.220 |
Why?
|
| Brain | 2 | 2025 | 1492 | 0.220 |
Why?
|
| Recombination, Genetic | 1 | 2025 | 239 | 0.220 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2024 | 19 | 0.220 |
Why?
|
| Hepatocytes | 1 | 2025 | 196 | 0.210 |
Why?
|
| Central Nervous System | 3 | 2020 | 193 | 0.210 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 13 | 0.200 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 691 | 0.200 |
Why?
|
| Capsid Proteins | 2 | 2020 | 92 | 0.200 |
Why?
|
| Gene Order | 2 | 2019 | 29 | 0.200 |
Why?
|
| Baculoviridae | 1 | 2022 | 26 | 0.200 |
Why?
|
| Insecta | 1 | 2022 | 37 | 0.190 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.190 |
Why?
|
| Tyrosinemias | 1 | 2021 | 19 | 0.190 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 34 | 0.190 |
Why?
|
| Transfection | 3 | 2025 | 675 | 0.190 |
Why?
|
| Microglia | 1 | 2024 | 230 | 0.180 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 7 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 264 | 0.180 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 28 | 0.180 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 841 | 0.180 |
Why?
|
| Lentivirus | 1 | 2021 | 63 | 0.170 |
Why?
|
| Communicable Diseases | 1 | 2021 | 85 | 0.170 |
Why?
|
| DNA, Viral | 2 | 2020 | 223 | 0.170 |
Why?
|
| Cisterna Magna | 1 | 2019 | 14 | 0.160 |
Why?
|
| Algorithms | 1 | 2025 | 979 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 41 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2021 | 227 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 37 | 0.160 |
Why?
|
| Ovalbumin | 1 | 2019 | 116 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2021 | 228 | 0.150 |
Why?
|
| Macular Degeneration | 1 | 2021 | 178 | 0.150 |
Why?
|
| Neoplasms | 2 | 2021 | 1233 | 0.150 |
Why?
|
| Osteoporosis | 1 | 2019 | 102 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2018 | 49 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 171 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2019 | 137 | 0.150 |
Why?
|
| Immunity, Innate | 2 | 2021 | 774 | 0.150 |
Why?
|
| Heterozygote | 1 | 2018 | 162 | 0.150 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 23 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2017 | 38 | 0.140 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 720 | 0.140 |
Why?
|
| Introns | 1 | 2017 | 104 | 0.140 |
Why?
|
| Computational Biology | 1 | 2019 | 334 | 0.140 |
Why?
|
| Alleles | 1 | 2018 | 411 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 91 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2018 | 130 | 0.130 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2095 | 0.130 |
Why?
|
| Alphavirus | 1 | 2015 | 3 | 0.120 |
Why?
|
| Colforsin | 1 | 2015 | 24 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 71 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2017 | 259 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2014 | 1471 | 0.120 |
Why?
|
| Cyclic AMP | 1 | 2015 | 142 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 229 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 674 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 111 | 0.110 |
Why?
|
| Luciferases | 1 | 2014 | 106 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 335 | 0.110 |
Why?
|
| Risk Factors | 1 | 2023 | 4990 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2014 | 192 | 0.110 |
Why?
|
| Metalloproteases | 1 | 2013 | 4 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 12 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1151 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 529 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 34 | 0.100 |
Why?
|
| Frozen Sections | 1 | 2012 | 10 | 0.100 |
Why?
|
| Base Sequence | 1 | 2014 | 1302 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 124 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 145 | 0.090 |
Why?
|
| Monocytes | 1 | 2013 | 345 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1953 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 620 | 0.090 |
Why?
|
| Mutation | 1 | 2018 | 2458 | 0.080 |
Why?
|
| Serogroup | 2 | 2020 | 32 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 177 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 602 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2016 | 2902 | 0.080 |
Why?
|
| Virus Assembly | 2 | 2020 | 53 | 0.080 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 234 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 836 | 0.070 |
Why?
|
| Myocardium | 1 | 2007 | 264 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2052 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 881 | 0.060 |
Why?
|
| Male | 6 | 2021 | 27790 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 858 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2024 | 203 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 381 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2021 | 15 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1368 | 0.050 |
Why?
|
| Dystrophin | 1 | 2021 | 31 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 88 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 25 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 49 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 76 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 355 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 98 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 44 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 197 | 0.040 |
Why?
|
| Vaccines | 1 | 2021 | 95 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 55 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 169 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 34 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1493 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 71 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 337 | 0.040 |
Why?
|
| Female | 4 | 2021 | 30772 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 126 | 0.040 |
Why?
|
| RNA Stability | 1 | 2019 | 97 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 108 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 222 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 187 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 163 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 170 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 259 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 173 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 293 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2018 | 23 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 254 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 868 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 248 | 0.030 |
Why?
|
| Endonucleases | 1 | 2018 | 80 | 0.030 |
Why?
|
| Blastocyst | 1 | 2018 | 70 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 112 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 743 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 26 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 354 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2019 | 590 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 515 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2016 | 79 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2015 | 7 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 496 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 48 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 394 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 39 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 259 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 912 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 59 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 230 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 23 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 648 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1999 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 461 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 474 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 18 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 9 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2013 | 31 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 38 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 149 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1513 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 738 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 333 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1143 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 174 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 96 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2215 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2057 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1033 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 264 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1555 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1911 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 41 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 217 | 0.020 |
Why?
|